A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity.
A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide receptor agonist in adolescents and young adults with hypothalamic obesity.